Patent: 9,470,695
✉ Email this page to a colleague
Summary for Patent: 9,470,695
Title: | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
Abstract: | The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using assays that detect one or more markers selected from the group consisting of Clusterin, Heart-type fatty acid binding protein, Hepatocyte growth factor, Interferon gamma, Interleukin-12 subunit beta, Interleukin-16, Interleukin-2, 72 kDa type IV collagenase, Matrix metalloproteinase-9, Midkine, and Serum amyloid P-component as diagnostic and prognostic biomarkers in renal injuries. |
Inventor(s): | Anderberg; Joseph (Encinitas, CA), Gray; Jeff (Solana Beach, CA), McPherson; Paul (Encinitas, CA), Nakamura; Kevin (Cardiff by the Sea, CA) |
Assignee: | ASTUTE MEDICAL, INC. (San Diego, CA) |
Application Number: | 14/673,353 |
Patent Claims: | see list of patent claims |
Details for Patent 9,470,695
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Smith & Nephew, Inc. | SANTYL | collagenase | Ointment | 101995 | 06/04/1965 | ⤷ Try a Trial | 2028-11-10 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |